MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Annovis Bio, Inc.

ANVS

#3749
Annovis Bio, Inc. Common Stock
1.9 3 USD
-0.52%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.91
1.93
Year Range
1.55
5.50
Daily Change
-0.52%
Monthly Change
+3.76%
6 month change
-61.86%
Year Change
-16.45%
Previous Close
1.9 4
Open
1.9 1
Low
1.9 1
High
1.9 3
Volume
115
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ANVS
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 66.87 M
  • Employee 7
  • Founded 2008
  • CEO Maria-luisa Maccecchini
  • Website www.annovisbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00PN9XD40
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

News

Investing Investing
ANVS
2025.12.18
Annovis Bio to launch long-term Parkinson’s drug study in January
Investing Investing
LLY BIIB JNJ NVO ANVS
2025.12.12
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Investing Investing
GWW FANG TPL LIN ANVS
2025.12.09
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Investing Investing
ANVS
2025.12.09
Annovis Bio director Hoffman buys $193,794 in shares
Investing Investing
HNRG STAA PGEN TPL ANVS
2025.11.24
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Investing Investing
ANVS
2025.11.22
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Benzinga Benzinga
ANVS
2025.11.17
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)
Investing Investing
ANVS
2025.11.06
Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion
Investing Investing
ANVS
2025.10.27
Annovis Bio raises $3.4 million in registered direct offering
Investing Investing
ANVS
2025.10.10
Annovis Bio raises $6 million in registered direct offering
Investing Investing
ANVS
2025.10.09
Annovis Bio reports buntanetap reduces inflammation in Alzheimer’s patients
Investing Investing
ANVS
2025.09.30
Canaccord Genuity reaffirms Buy rating on Annovis Bio stock

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd